News and History
Life Science News and History
LifeScienceHistory.com (LSH), “Where history is made daily” is a comprehensive compendium of life science. Simply put, we dig history and we mine data daily.
LSH grew from frustration with the difficulty in finding historical information about life science, and the industry in general. Most seemed to be the same old duped lists of facts, rarely with images, nor links for more information, and almost never sourced.
LSH news and history are presented in an easily readable format with images, all sourced, linked and content updated where possible, because history is made daily. You can also search by state, province or nation, and find information about your locale. Plus you can search our one-of-a-kind ‘Genealogy on Demand‘ and see what companies are spin-offs from universities and non-profit organizations in your state or province.
-
Joint Service Program Delivers Genetic sequencing technology to the Modern Battlefield
Read More: Joint Service Program Delivers Genetic sequencing technology to the Modern BattlefieldOn Jun. 12, 2026, the U.S. Naval Research Laboratory (NRL), in partnership with the Defense Threat Reduction Agency (DTRA) and multiple Army and Navy…
-
University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research Center
Read More: University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research CenterOn Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from the National Institutes of Health to…
-
the American College of Obstetricians & Gynecologists released its 2026 maternal immunization schedule
Read More: the American College of Obstetricians & Gynecologists released its 2026 maternal immunization scheduleOn Jun. 10, 2026, the American College of Obstetricians & Gynecologists (ACOG) released its 2026 maternal immunization schedule. The new schedule is endorsed by…
-
FDA Expands Sunscreen Options for the First Time in 20 Years
Read More: FDA Expands Sunscreen Options for the First Time in 20 YearsOn Jun. 9, 2026, the U.S. Food and Drug Administration (FDA) announced it has added bemotrizinol to the list of permitted sunscreen active ingredients,…
-
China performs world’s first combined transplant of pig liver and kidney to human
Read More: China performs world’s first combined transplant of pig liver and kidney to humanOn Jun. 9, 2026, Chinese surgeons announced they have carried out the world’s first combined transplant of a gene-edited pig liver and two pig…
-
GSK enters agreement to acquire Nuvalent for $10.6 Billion
Read More: GSK enters agreement to acquire Nuvalent for $10.6 BillionOn Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage biopharmaceutical company focused on creating precisely…
-
First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
Read More: First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicineOn Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental…
-
Incyte to Acquire Vega Therapeutics, Subsidiary of Star Therapeutics, for $1.25 billion, Expanding its Hematology Portfolio into Bleeding Disorders
Read More: Incyte to Acquire Vega Therapeutics, Subsidiary of Star Therapeutics, for $1.25 billion, Expanding its Hematology Portfolio into Bleeding DisordersOn Jun. 8, 2026, Incyte announced it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for $1.25 billion. Star Therapeutics will…
-
Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology Pipeline
Read More: Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology PipelineOn Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly Bio, a biotechnology company advancing its…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
Read More: Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billionOn Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics. Under the terms of…
-
study finds Indoor air contains greater diversity of airborne fungi than previously thought
Read More: study finds Indoor air contains greater diversity of airborne fungi than previously thoughtOn Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor fungal air pollution, revealing that homes…
-
Debugging California: Fighting mosquitoes with mosquitoes
Read More: Debugging California: Fighting mosquitoes with mosquitoesOn Jun. 4, 2026, a program called Debug—run by Google’s health research arm—has applied to the EPA to release up to 32 million sterile…
-
Bioprinting Cartilage, Producing Stem Cells Fill ISS Research Schedule
Read More: Bioprinting Cartilage, Producing Stem Cells Fill ISS Research ScheduleOn Jun. 4, 2026, 3D bioprinting and stem cell research were the main research topics aboard the International Space Station (ISS). The Expedition 74…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
Read More: Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billionOn Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with pharma major Eli Lilly, worth up…
-
Flesh-eating screwworm may have been detected in South Texas, USDA says
Read More: Flesh-eating screwworm may have been detected in South Texas, USDA saysOn Jun. 3, 2026, an infestation of the flesh-eating screwworm parasite may have been detected in South Texas, and a sample is at a…
-
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 Billion
Read More: Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 BillionOn Jun. 3, 2026, Alnylam Pharmaceuticals, the leading RNAi therapeutics company, and Inceptive Nucleics, which builds foundation models of life, announced a strategic collaboration…
-
Measles cases mount in Florida, highest number reported in 25 years
Read More: Measles cases mount in Florida, highest number reported in 25 yearsOn Jun. 2, 2026, The Florida Department of Health said there have been 154 measles cases in the state this year, with the most…
-
Microrobots repair spinal cord
Read More: Microrobots repair spinal cordOn Jun. 2, 2026, a research team from ETH Zurich and the University of Zurich (UZH) announced it has developed a novel approach to…
-
CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response
Read More: CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak responseOn Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued development of a pioneering vaccine platform…
-
CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
Read More: CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidatesOn May 31, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced it will urgently accelerate development of three investigational vaccines targeting the Bundibugyo…
